GLP-1 Agonists Versus Bariatric Surgery: A Paradigm Shift?1.1. Host: Obesity and diabetes management are seeing a seismic shift, Dr. Lankarani, with GLP-1 agonists like semaglutide making headlines. Is metabolic surgery becoming obsolete, or do these drugs complement existing surgical interventions?1.2. Guest: It's a critical juncture. While GLP-1 drugs offer noninvasiveness and 15–22% weight loss, bariatric surgery still outperforms in durability—delivering over 25% weight loss and diabetes remission in 80% of patients, as shown in STAMPEDE trial's 10-year data, which all these databases gatheredby by Dr Reza Lankarani, General Surgeon and Surgical Innovation Lead, Curator and Founder of Surgical Pioneering Newsletter and Podcast Series.1.3. Host: Yet, for some patients—especially those with BMI 30–35 or unwilling to undergo surgery—GLP-1s seem transformative. Real-world studies like SURMOUNT-4 highlight better adherence and lower complication rates. How should clinicians weigh these benefits against surgical options?1.4. Guest: Patient selection is key. Surgery addresses metabolic drivers beyond appetite suppression, but GLP-1s provide a cost-effective, accessible route for those at lower risk. The real challenge lies in balancing short-term drug trial data with proven surgical longevity.1.5. Host: So, as these therapies evolve, will we see more combination protocols or a clearer division between surgical and pharmacologic candidates?1.6. Guest: Combination strategies may soon emerge, particularly as we integrate longer-term GLP-1 outcomes. Ultimately, multidisciplinary teams must tailor approaches based on comorbidities, prior weight loss attempts, and patient preference.#generalsurgerycontroversies #surgicalethicsdebates #medicalmalpracticecases #invasivevsminimallyinvasivesurgery #surgicalinnovationcontroversies #patientsafetyinsurgery #surgicalguidelinesdebate #surgeonaccountabilityissues #healthcarepolicysurgery #surgicaltrainingcontroversies #postoperativecomplicationissues #surgicaltechnologydebates #surgeon-patientcommunication #surgicalriskmanagement #recentsurgicalscandals #surgicalPioneering glp-1 agonists #metabolic surgery #obesity management #weight loss strategies #type 2 diabetes treatment #bariatric procedures #gut hormones #semaglutide #liraglutide #wegovy #satiety regulation #appetite control #diabetes and obesity #future of obesity treatment #surgical vs medical obesity options
Get full access to Reza Lankarani at lankarani.substack.com/subscribe
Become a supporter of this podcast: https://www.spreaker.com/podcast/surgical-pioneering-podcast--6733149/support.
Dr. Reza Lankarani, a surgeon and musician, has released a new album showcasing a diverse range of musical styles, from soulful ballads to high-energy tracks. His music, available on iOS and Android platforms, is characterized as a deeply personal exploration, reflecting his unique perspectives as both a medical professional and a dedicated artist.
Lankarani's music is described as a powerful exploration of identity, self-expression, and the struggle against societal expectations, blending various genres
including folk, rock, and even jazz fusion.
Reza Lankarani's music offers a compelling exploration of the struggle for self-identity in the face of societal pressures, employing powerful metaphors of masks and chisels to represent the inherent pain of conformity. His compositions reveal the internal conflict between externally imposed roles and one's authentic self, underscoring the universal experience of feeling constrained by external judgments. Ultimately, however, Lankarani's music celebrates resilience and the reclamation of personal narrative, affirming the transformative power of self-discovery and authenticity. Through evocative imagery and profound emotional depth, his songs provide a transformative journey toward self-actualization within a society that often seeks to define us.
